GQG Partners LLC Makes New Investment in The Allstate Corporation $ALL

GQG Partners LLC purchased a new stake in The Allstate Corporation (NYSE:ALL) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 5,235,375 shares of the insurance provider’s stock, valued at approximately $1,245,710,000. Allstate makes up about 2.3% of GQG Partners LLC’s investment portfolio, making the stock its 13th largest holding.

A number of other institutional investors and hedge funds also recently made changes to their positions in ALL. MV Capital Management Inc. acquired a new stake in shares of Allstate in the 4th quarter valued at about $25,000. Gables Capital Management Inc. acquired a new position in Allstate during the 2nd quarter worth approximately $26,000. Navalign LLC bought a new position in Allstate in the fourth quarter worth approximately $27,000. Kelleher Financial Advisors acquired a new stake in Allstate in the second quarter valued at approximately $28,000. Finally, Evolution Wealth Management Inc. increased its holdings in shares of Allstate by 7,000.0% during the first quarter. Evolution Wealth Management Inc. now owns 142 shares of the insurance provider’s stock valued at $29,000 after acquiring an additional 140 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.

Insider Activity

In related news, Director Andrea Redmond sold 2,225 shares of the stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $202.91, for a total transaction of $451,474.75. Following the completion of the transaction, the director owned 2,225 shares in the company, valued at approximately $451,474.75. This represents a 50.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Mario Rizzo sold 56,225 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $264.48, for a total transaction of $14,870,388.00. Following the sale, the chief operating officer owned 82,227 shares of the company’s stock, valued at $21,747,396.96. This trade represents a 40.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 91,446 shares of company stock valued at $24,208,675 in the last ninety days. 1.55% of the stock is currently owned by insiders.

Allstate Price Performance

Shares of NYSE ALL opened at $253.82 on Friday. The company has a market capitalization of $64.18 billion, a PE ratio of 5.07, a PEG ratio of 0.39 and a beta of 0.16. The company has a quick ratio of 0.36, a current ratio of 0.36 and a debt-to-equity ratio of 0.24. The stock’s 50 day moving average price is $250.34 and its 200-day moving average price is $224.95. The Allstate Corporation has a twelve month low of $188.08 and a twelve month high of $277.22.

Allstate (NYSE:ALL) last issued its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, beating analysts’ consensus estimates of $6.06 by $2.93. The company had revenue of $18.60 billion during the quarter, compared to the consensus estimate of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%.Allstate’s revenue was up 11.8% on a year-over-year basis. During the same period last year, the business posted $5.94 earnings per share. On average, equities analysts anticipate that The Allstate Corporation will post 34.45 EPS for the current year.

Allstate Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Monday, August 31st will be given a dividend of $1.08 per share. The ex-dividend date of this dividend is Monday, August 31st. This represents a $4.32 annualized dividend and a dividend yield of 1.7%. Allstate’s dividend payout ratio (DPR) is currently 8.63%.

Key Allstate News

Here are the key news stories impacting Allstate this week:

• Positive Sentiment: Zacks Research raised several Allstate EPS forecasts, including estimates for Q3 2026, FY2027, FY2028, Q1 2027, Q4 2027 and Q2 2028. Zacks maintains a “Strong-Buy” rating, supporting the view that underwriting performance and earnings power may remain resilient. Allstate earnings estimates
• Positive Sentiment: A Zacks screen identified ALL as a high-return-on-equity, cash-rich stock that could appeal to investors seeking quality and financial strength during volatile markets. High-ROE stocks article
• Neutral Sentiment: Allstate opened a new Dallas auto laboratory to train claims adjusters on increasingly complex vehicle technology. The initiative could improve claims accuracy and customer service over time, but it is unlikely to materially affect near-term earnings. Allstate Dallas auto lab
• Negative Sentiment: Keefe, Bruyette & Woods downgraded ALL from “hold” to “moderate sell,” adding to investor caution around the stock’s valuation and outlook. Allstate analyst downgrade
• Negative Sentiment: Allstate estimated July catastrophe losses of $682 million pretax, or $539 million after tax. The losses bring pretax catastrophe costs for the current aggregate year to approximately $2.402 billion, creating pressure on underwriting margins and near-term earnings. Allstate July 2026 monthly release
• Negative Sentiment: Zacks Research lowered its Q2 2027 and Q4 2026 EPS estimates, indicating that analysts still see some periods of earnings pressure despite upward revisions elsewhere. Allstate earnings estimates

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Roth Capital set a $300.00 target price on Allstate in a report on Thursday, August 6th. Barclays boosted their price target on shares of Allstate from $213.00 to $226.00 and gave the company an “underweight” rating in a research note on Thursday, August 6th. JPMorgan Chase & Co. upped their price objective on shares of Allstate from $282.00 to $292.00 and gave the stock an “overweight” rating in a report on Tuesday, August 11th. Morgan Stanley set a $265.00 price objective on shares of Allstate in a research note on Tuesday, August 11th. Finally, Citigroup cut shares of Allstate from a “neutral” rating to a “sell” rating and lifted their price objective for the company from $226.00 to $240.00 in a report on Tuesday, August 11th. Four analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, eight have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Allstate has an average rating of “Hold” and a consensus target price of $265.26.

About Allstate

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.